Icon
+91 94997 68112
Login Register

Atelvia - (35 mg; Tablet, Delayed Release)

Risedronate Sodium Allergan
35 mg; Tablet, Delayed Release
Less Than $1000 mn
Less Than 5
Less Than 5
None None
Less Than 5
Less Than 5
Indicated for the treatment of osteoporosis in postmenopausal women.
Yes
**** ** *** *** *** ***** **** ** **** ******* '*** (*** *, ****), '*** (*** *, ****), '*** (*** **, ****). ***** ******* *** ***** **** ***** **** ** **** ******* *******. ****** *** ******* ******* *** ***** ******* *** ********** **** ******. *** ********** ********* **** **** ***** ******** ***** *** ******* ******* ***** **** *** ******* ** ***** *** *******. **** **** *** *********** ******* ** ***** *** *** ****** ********* ********. ******* **** ******** *** ******* *********** ** ********** ******* ** *** ******** *****. ***** *** ****** ********* ******* ** *** ******* ******* ** ****** ***** *** ******* ** ****** ** ****. *** *********** *** **** ******* ***** ** *** *** ******** ** **** ** * ******** ******* ******* *** *** *********** ***** ******** **** **** ******** ********.
Atelvia Patent 1 Patent 2 Patent 3
****** ******* ******* *******
**** ******* ******* *******
*** (*******) ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** ***** **, **** ******* **** ****** **** ********
**** *** \ *** *** **, **** ******* ******** ** *** **, ****
*** (*******) ** \ ** *** **, **** ******* ******** ******** ** **** **, ****
  1. *** **, **** : ****** ***** * **** ******* ****** ** ******** ***** ** **.
  2. *** **, **** : **** ******** ****** ***** *** **** ** *** ******* **** ******* '*** (*** *, ****), '*** (*** *, ****), '*** (*** **, ****)
  3. *** **, **** : ****** ***** * **** ******* **** ** ******** ***** ** **.
  4. *** **, **** : ******* ******** ****** ******** ***** ** **** ** *** ******* **** ******* '*** (*** *, ****), '*** (*** *, ****), '*** (*** **, ****)
  5. *** **, **** : ****** ***** * **** ******* ******* ** ******** ***** ** **.
  6. *** **, **** : ****** ***** * **** ******* ***** ** ******** ***** ** ** ** ***** ***** * **** ** *** ******* **** ******* '*** (*** *, ****), '*** (*** *, ****), '*** (*** **, ****)
  7. *** **, **** : ******* *** ****** ******* * ********** ***** *** ***** ** ********** *** *** *****.
  8. *** **, **** : ***** *** ****** ******* * ********** ***** *** ***** ** ********** *** *** *****.
  9. *** *, **** : ******** ***** ***** **** *** ****** '*** *** '*** ** *******.
  10. *** **, **** : **** ******** *** *******.
  11. *** *, **** : ****** ******** ******** *** ******** ** ******* *******.
  12. *** **, **** : ******* ******* ********** ******** *****'* ********.
  13. *** *, **** : ********** ********* **** ******

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.